Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

Signatera CDx Receives FDA Approval as Companion Diagnostic for Muscle-Invasive Bladder Cancer

  • The Pharma Data
  • May 16, 2026

Natera Receives FDA Approval for Signatera CDx as First Blood-Based MRD Companion Diagnostic in Muscle-Invasive Bladder Cancer Natera announced that the U.S. Food and Drug Administration has approved Signatera CDx…

Read MoreSignatera CDx Receives FDA Approval as Companion Diagnostic for Muscle-Invasive Bladder Cancer
  • Research

Amylyx Pharmaceuticals Publishes Phase 2 HELIOS Trial Data for AMX0035 in JCI

  • The Pharma Data
  • May 16, 2026

Amylyx Publishes Phase 2 HELIOS Trial Results Showing Continued Benefits of AMX0035 in Wolfram Syndrome Amylyx Pharmaceuticals announced that detailed Week 24 and Week 48 findings from the Phase 2…

Read MoreAmylyx Pharmaceuticals Publishes Phase 2 HELIOS Trial Data for AMX0035 in JCI
  • Press Releases

ICUS Applauds New Proposal Advancing CEUS Training for Sonographers

  • The Pharma Data
  • May 16, 2026

ICUS Supports New Sonography Training Standards Expanding Education in Contrast Enhanced Ultrasound International Contrast Ultrasound Society has expressed strong support for newly proposed accreditation standards that could significantly expand education…

Read MoreICUS Applauds New Proposal Advancing CEUS Training for Sonographers
  • Regulatory

Bayer Launches Midol® in Motion Campaign to Promote PMS Relief Through Physical Activity

  • The Pharma Data
  • May 16, 2026

Bayer Launches Midol in Motion Campaign to Support PMS Symptom Relief Through Movement and Education Bayer has announced the launch of “Midol in Motion,” a new awareness and education campaign…

Read MoreBayer Launches Midol® in Motion Campaign to Promote PMS Relief Through Physical Activity
  • Business

Enveric Biosciences Announces First Quarter 2026 Financial Results and Business Update

  • The Pharma Data
  • May 16, 2026

Enveric Biosciences Reports First Quarter 2026 Results and Advances Non-Hallucinogenic Neuroplastogen Pipeline Enveric Biosciences reported financial results for the first quarter ended March 31, 2026, while also providing an extensive…

Read MoreEnveric Biosciences Announces First Quarter 2026 Financial Results and Business Update
  • Research

Kraken Regen Unveils Next-Generation Collagen Hydrogel for Regenerative Medicine Research

  • The Pharma Data
  • May 16, 2026

Kraken Regen Launches Advanced Collagen Platform Technology to Support Regenerative Medicine Research Kraken Regen has announced the launch of its new Collagen Platform Technology, introducing a high-purity collagen biomaterial engineered…

Read MoreKraken Regen Unveils Next-Generation Collagen Hydrogel for Regenerative Medicine Research
  • Business

Sensei Biotherapeutics Reports Q1 2026 Financial Results and Highlights Corporate Progress

  • The Pharma Data
  • May 16, 2026

Sensei Biotherapeutics Advances PIKTOR Oncology Program Following Faeth Acquisition and $200 Million Financing Sensei Biotherapeutics reported its financial results for the first quarter ended March 31, 2026, while also outlining…

Read MoreSensei Biotherapeutics Reports Q1 2026 Financial Results and Highlights Corporate Progress
  • News

Kariya and NeuraLight Partner to Evaluate Brain Effects of Next-Generation GLP-1 Therapies

  • The Pharma Data
  • May 15, 2026

Kariya and NeuraLight Collaborate to Evaluate Brain Effects of Next-Generation GLP-1 Therapies Kariya Pharmaceuticals and NeuraLight have announced a strategic partnership aimed at advancing the development of next-generation brain-focused GLP-1…

Read MoreKariya and NeuraLight Partner to Evaluate Brain Effects of Next-Generation GLP-1 Therapies
  • Press Releases

Glooko Receives FDA 510(k) Clearance for EndoTool IV Cloud System

  • The Pharma Data
  • May 15, 2026

Glooko Receives FDA 510(k) Clearance for EndoTool IV Cloud Platform Glooko, Inc., a global digital health company specializing in diabetes management and glycemic safety solutions, has announced that the U.S.…

Read MoreGlooko Receives FDA 510(k) Clearance for EndoTool IV Cloud System
  • Research

Worldwide Clinical Trials Expands Leadership Team to Advance Global Growth and Therapeutic Expertise

  • The Pharma Data
  • May 15, 2026

Worldwide Clinical Trials Expands Leadership Team to Enhance Global Reach and Therapeutic Expertise Worldwide Clinical Trials, a global contract research organization (CRO) focused on delivering specialized clinical development services for…

Read MoreWorldwide Clinical Trials Expands Leadership Team to Advance Global Growth and Therapeutic Expertise
  • Regulatory

Affinia Therapeutics Showcases AFTX-201 Cardiomyopathy Data and AAV Platform Advances at ASGCT 2026

  • The Pharma Data
  • May 15, 2026

Affinia Therapeutics Highlights Advances in Gene Therapy Pipeline and Manufacturing at ASGCT 2026 Affinia Therapeutics showcased major progress across its cardiovascular and central nervous system gene therapy programs during multiple…

Read MoreAffinia Therapeutics Showcases AFTX-201 Cardiomyopathy Data and AAV Platform Advances at ASGCT 2026
  • News

Ionis Pharmaceuticals Partner Biogen Reports Positive Phase 2 Results for Diranersen in Early Alzheimer’s Disease

  • The Pharma Data
  • May 15, 2026

Ionis and Biogen Report Promising Phase 2 Results for Tau-Targeting Alzheimer’s Therapy Diranersen Ionis Pharmaceuticals and Biogen have announced encouraging topline findings from the Phase 2 CELIA clinical study evaluating…

Read MoreIonis Pharmaceuticals Partner Biogen Reports Positive Phase 2 Results for Diranersen in Early Alzheimer’s Disease
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Savara Inc. Highlights Long-Term IMPALA-2 Phase 3 Data for Molgramostim in aPAP
  • SERI Lugano Launches Global Scientific Initiative Focused on Light-Based Neuroscience and Pineal Gland Research
  • Texas Cancer Institute Adopts Kallisio Technologies Stentra™ as Standard Oral Immobilization Solution
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.